Mallinckrodt buys immunotherapy maker Therakos for $1.33 billion: Reuters

Dublin-based drugmaker Mallinckrodt Plc (MNK.N) said it would buy immunotherapy company Therakos Inc in a deal valued at about $1.33 billion, its second major acquisition this year aimed at strengthening its hospital offerings.

DealsNorth AmericaUSBriefs